Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
about
Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.Evaluation of the clinical efficacy of asenapine in schizophreniaTranslational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in SchizophreniaCortical parvalbumin interneurons and cognitive dysfunction in schizophreniaDendritic spine pathology in schizophreniaInefficient Preparatory fMRI-BOLD Network Activations Predict Working Memory Dysfunctions in Patients with Schizophrenia.Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosisGamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5/6(+/-) mice.Emotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanismsInvestigating the mechanism(s) underlying switching between states in bipolar disorderInvestigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophreniaAdjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacyAttentional processing in C57BL/6J mice exposed to developmental vitamin D deficiencyEffects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality DisorderAnimal models of bipolar mania: The past, present and future.Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia SyndromeModeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia.N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement.Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.Further evidence for ClockΔ19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating.The effects of ketamine and risperidone on eye movement control in healthy volunteers.Mouse pharmacological models of cognitive disruption relevant to schizophrenia.Predictive animal models of mania: hits, misses and future directions.Hyperactivity, startle reactivity and cell-proliferation deficits are resistant to chronic lithium treatment in adult Nr2e1(frc/frc) miceReduced multisensory integration in patients with schizophrenia on a target detection task.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Aberrant frontoparietal function during recognition memory in schizophrenia: a multimodal neuroimaging investigation.Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task.Cognitive Effort and Schizophrenia Modulate Large-Scale Functional Brain ConnectivityThe 5-choice continuous performance test: evidence for a translational test of vigilance for mice.Advancing paternal age is associated with deficits in social and exploratory behaviors in the offspring: a mouse model.Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials.Correlates of real world executive dysfunction in bipolar I disorder.Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.Multifamily group psychoeducation and cognitive remediation for first-episode psychosis: a randomized controlled trial.Cognitive task performance and symptoms contribute to personality abnormalities in first hospitalized schizophrenia
P2860
Q21133801-9FC0550A-9BB1-459A-9306-990E736FBB50Q24630385-9EE6B879-B4D7-4673-85E0-BC476949C58AQ26801568-F43A9D5F-0589-46BD-A20D-54A43086AC42Q26822851-EB3F82B9-26E1-4986-BE3D-D36C192D9620Q26991935-E8AC9930-DFA7-466F-9639-9C94FE2850FFQ27303752-C82B3ABC-93E9-415C-9858-9CF6BB3C54C1Q27303931-80C0AA1B-D4C0-4167-B01D-AB5B0AF3BAEBQ27305944-B7AEA52F-529F-4C76-824B-1823508554D0Q28073684-C96DCCAB-25BA-4E55-831C-5599766AD180Q28084519-9C50547B-2FA1-4433-A04B-02E4C99BCDCEQ28085253-B90EBF21-DA7B-4BF0-B683-498A19D57D3EQ28240120-BA07AB3A-1F06-4C62-9778-25F16D192A77Q28297813-9EFD45B6-70E1-4267-840F-B23482D32B8FQ28730312-3D83F353-2984-4015-BBFE-1A45D6C9AA23Q29038503-CBEA2688-02A5-45CB-955D-A93113FC6B76Q30357298-97F04B69-404D-43B8-9A57-A2C45F4A5C23Q30357827-3E8D49B7-2116-418C-93E9-CC9C1D979E23Q30375478-F2BDDA29-02D4-400D-9545-622A414538DCQ30396291-31224784-6A46-4014-8B93-22F2C9E6D601Q30396775-67BFA7B7-C1A3-4098-9183-762AEE34FE92Q30418674-82CB6512-E5EC-4923-B247-FDA63B4C39A1Q30427199-C89635A1-A38D-407C-A011-874F9F8955FCQ30428422-20855DB7-D467-4EF4-A597-5EDD9BDB8539Q30434813-330CBADF-4651-4D44-9492-539523915AF9Q30437913-58D1A2C9-F5F7-47D2-A8C3-CAFCAAFF99D6Q30457807-1E25619B-B9C1-4557-8742-A837CD20D7FCQ30462823-63514387-6E96-46A6-9C36-51016674C22EQ30469863-A86B2702-CAC0-4C22-84DA-5457872FCB25Q30474680-AF7F7486-09A8-43C3-9EE4-4F700F719FABQ30489404-B42D1CD3-16EC-42BA-9898-AAD3CDD92CFCQ30491227-39F89D5C-32D5-4D11-AB44-BAF90336F4BBQ30492142-5C371068-21FC-4404-925D-AA8DFC91784CQ30667666-E96F5D9B-6FCC-47CF-8FCC-78D614CB98F8Q33401264-AEE3C72C-E61C-4394-A6CF-4CFEB84CA461Q33521226-529BF78A-5F4F-4E40-BBDA-A35FD79D04BCQ33637930-9D880B0C-D71B-46DB-8947-052144053B6CQ33710762-AF3689A6-CCBD-4356-90F0-72F6C37E091CQ33768017-CDE548FC-5104-4FEA-9D7B-7091F62A6AA6Q33791337-B6B7D840-C128-4263-8516-BA4BCD2636BAQ33878552-0C5470DF-F2E4-4650-BEAF-1FD18E5D7078
P2860
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@ast
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@en
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@en-gb
type
label
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@ast
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@en
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@en-gb
prefLabel
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@ast
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@en
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@en-gb
P3181
P356
P1476
Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder
@en
P3181
P356
10.4088/JCP.1006E12
P577
2006-10-15T00:00:00Z